List of anti-aging patents

Patents where

Current Assignee

Industry

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 12119091 Utilizing masked autoencoder generative models to extract microscopy representation autoencoder embeddings	Patent 12119091 was granted and assigned to Recursion Pharmaceuticals on October, 2024 by the United States Patent and Trademark Office.	Recursion Pharmaceuticals	Recursion Pharmaceuticals	United States Patent and Trademark Office	12119091	October 15, 2024
‌ US Patent 11525146 Expression constructs, fusogenic lipid-based nanoparticles and methods of use thereof		Oisin Biotechnologies	Oisin Biotechnologies	United States Patent and Trademark Office	11525146	December 13, 2022
‌ US Patent 11603543 Fusogenic lipid nanoparticles for target cell-specific production of a therapeutic protein		Oisin Biotechnologies	Oisin Biotechnologies	United States Patent and Trademark Office	11603543	March 14, 2023
‌ US Patent 11791019 Systems and methods for high throughput compound library creation	Patent 11791019 was granted and assigned to Recursion Pharmaceuticals on October, 2023 by the United States Patent and Trademark Office.	Recursion Pharmaceuticals	Recursion Pharmaceuticals	United States Patent and Trademark Office	11791019	October 17, 2023
‌ US Patent 11501853 Preemptible-based scaffold hopping	Patent 11501853 was granted and assigned to Recursion Pharmaceuticals on November, 2022 by the United States Patent and Trademark Office.	Recursion Pharmaceuticals	Recursion Pharmaceuticals	United States Patent and Trademark Office	11501853	November 15, 2022
‌ US Patent 11318168 Human tissue derived compositions and uses thereof		Osiris Therapeutics	Osiris Therapeutics	United States Patent and Trademark Office	11318168	May 3, 2022
‌ US Patent 11403521 Mutual information adversarial autoencoder		Insilico Medicine	Insilico Medicine	United States Patent and Trademark Office	11403521	August 2, 2022
‌ US Patent 11464809 Umbilical tissue compositions and methods of use	Patent 11464809 was granted and assigned to Osiris Therapeutics on October, 2022 by the United States Patent and Trademark Office.	Osiris Therapeutics	Osiris Therapeutics	United States Patent and Trademark Office	11464809	October 11, 2022
‌ US Patent 11393560 Systems and methods for high throughput compound library creation	Patent 11393560 was granted and assigned to Recursion Pharmaceuticals on July, 2022 by the United States Patent and Trademark Office.	Recursion Pharmaceuticals	Recursion Pharmaceuticals	United States Patent and Trademark Office	11393560	July 19, 2022
‌ US Patent 11397152 Device and method of measuring animal urine			Recursion Pharmaceuticals	United States Patent and Trademark Office	11397152	July 26, 2022
‌ US Patent 11638725 Methods of manufacture of immunocompatible chorionic membrane products	Patent 11638725 was granted and assigned to Osiris Therapeutics on May, 2023 by the United States Patent and Trademark Office.	Osiris Therapeutics	Osiris Therapeutics	United States Patent and Trademark Office	11638725	May 2, 2023
‌ US Patent 10272116 Immunocompatible amniotic membrane products	Patent 10272116 was granted and assigned to Osiris Therapeutics on April, 2019 by the United States Patent and Trademark Office.	Osiris Therapeutics	Osiris Therapeutics	United States Patent and Trademark Office	10272116	April 30, 2019
‌ US Patent 7892829 Cardiac muscle regeneration using mesenchymal stem cells	Patent 7892829 was granted and assigned to Osiris Therapeutics on February, 2011 by the United States Patent and Trademark Office.		Osiris Therapeutics	United States Patent and Trademark Office	7892829	February 22, 2011
‌ US Patent 9956248 Methods of manufacture of therapeutic products comprising vitalized placental dispersions	Patent 9956248 was granted and assigned to Osiris Therapeutics on May, 2018 by the United States Patent and Trademark Office.	Osiris Therapeutics	Osiris Therapeutics	United States Patent and Trademark Office	9956248	May 1, 2018
‌ US Patent 10502738 HLA G-modified cells and methods	Patent 10502738 was granted and assigned to AgeX Therapeutics on December, 2019 by the United States Patent and Trademark Office.	AgeX Therapeutics	AgeX Therapeutics	United States Patent and Trademark Office	10502738	December 10, 2019
‌ US Patent 11361438 Techniques for analyzing and detecting executional artifacts in microwell plates	Patent 11361438 was granted and assigned to Recursion Pharmaceuticals on June, 2022 by the United States Patent and Trademark Office.	Recursion Pharmaceuticals	Recursion Pharmaceuticals	United States Patent and Trademark Office	11361438	June 14, 2022
‌ US Patent 11590173 Methods of manufacture of therapeutic products comprising vitalized placental dispersions		Osiris Therapeutics	Osiris Therapeutics	United States Patent and Trademark Office	11590173	February 28, 2023
‌ US Patent 11510947 Methods of manufacture of immunocompatible amniotic membrane products	Patent 11510947 was granted and assigned to Osiris Therapeutics on November, 2022 by the United States Patent and Trademark Office.	Osiris Therapeutics	Osiris Therapeutics	United States Patent and Trademark Office	11510947	November 29, 2022
‌ US Patent 11406735 Methods of manufacturing cartilage products	Patent 11406735 was granted and assigned to Osiris Therapeutics on August, 2022 by the United States Patent and Trademark Office.	Osiris Therapeutics	Osiris Therapeutics	United States Patent and Trademark Office	11406735	August 9, 2022
‌ US Patent 11590172 Immunocompatible chorionic membrane products		Osiris Therapeutics	Osiris Therapeutics	United States Patent and Trademark Office	11590172	February 28, 2023
‌ US Patent 11413373 Disrupted cartilage products	Patent 11413373 was granted and assigned to Osiris Therapeutics on August, 2022 by the United States Patent and Trademark Office.	Osiris Therapeutics	Osiris Therapeutics	United States Patent and Trademark Office	11413373	August 16, 2022
‌ US Patent 9801970 Decorative fragrance dispensing system	Patent 9801970 was granted and assigned to Ambrosia (company) on October, 2017 by the United States Patent and Trademark Office.		Ambrosia (company)	United States Patent and Trademark Office	9801970	October 31, 2017
‌ US Patent 11535661 RAGE fusion proteins with improved stability and ligand binding affinity and uses thereof		BioAge Labs	BioAge Labs	United States Patent and Trademark Office	11535661	December 27, 2022
‌ US Patent 11445981 Survival prediction using methylomic profiles		BioAge Labs	BioAge Labs	United States Patent and Trademark Office	11445981	September 20, 2022
‌ US Patent 11512282 Enhanced placental stem cells and uses thereof	Patent 11512282 was granted and assigned to Celularity on November, 2022 by the United States Patent and Trademark Office.	Celularity	Celularity	United States Patent and Trademark Office	11512282	November 29, 2022

Results per page:

97 results

0 selected

97 results

0 selected